L-DOPA促进早期糖尿病视网膜病变治疗后神经血管与突触稳态
本研究在链脲佐菌素诱导的糖尿病小鼠中评估L-DOPA/卡比多巴治疗后对视网膜和视觉功能的保护作用及其转录组变化。结果显示L-DOPA治疗结束后至少两周内,ERG振荡电位时序和OMR表现仍受保护,闪烁光诱导的静脉扩张也维持改善。基因共表达网络分析发现与突触功能和细胞骨架组织相关的模块与功能保护相关。
要点
- L-DOPA治疗可保护糖尿病小鼠ERG振荡电位时序和OMR表现至治疗结束后至少两周。
- L-DOPA维持闪烁光诱导的静脉扩张改善,动脉扩张呈保护趋势。
- 转录组分析提示L-DOPA的保护与突触活动和结构完整性相关基因程序有关。
核心结论
- L-DOPA可恢复早期糖尿病视网膜病变小鼠的视网膜神经血管功能,且治疗后效应持续,并与支持突触活动和结构完整性的转录程序相关。
研究设计与样本
- 研究使用链脲佐菌素诱导的糖尿病小鼠,通过ERG和OMR确认功能缺陷后,分别给予持续L-DOPA/卡比多巴四週、L-DOPA/卡比多巴两週后洗脱两週或赋形剂四週。
- 在最后两週重复功能评估并评估闪烁光诱导的视网膜血管扩张,随后进行视网膜组织bulk RNA测序、差异基因表达分析和加权基因共表达网络分析。
主要发现
- 糖尿病小鼠L-DOPA治疗后,ERG振荡电位时序和OMR表现至治疗结束后至少两週仍受保护。
- 闪烁光诱导的静脉扩张维持治疗后改善,动脉扩张呈保护趋势。
- 经历L-DOPA洗脱的糖尿病小鼠与持续L-DOPA治疗的糖尿病小鼠之间差异表达基因相当。
- 基因共表达网络分析在L-DOPA治疗的糖尿病小鼠中识别出与突触功能和细胞骨架组织相关的不同模块,并与功能保护相关。
临床怎么用
- 在早期糖尿病视网膜病变中,L-DOPA治疗可能提供治疗后持续的保护效应,支持突触活动和结构完整性的转录程序或可作为干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Although previous work has shown a post-treatment protective effect of levodopa (L-DOPA) on retinal function in early-stage diabetic retinopathy (DR) in humans, its underlying biology is unknown. This study investigated L-DOPA's post-treatment functional protection with transcriptional changes in the diabetic murine retina. METHODS: Assessing retinal and visual function with electroretinography (ERG) and optomotor response (OMR), functional deficits were confirmed in streptozotocin (STZ)-induced diabetic mice. Control and diabetic mice were then treated with continuous L-DOPA/carbidopa (four weeks), L-DOPA/carbidopa (two weeks) followed by washout (two weeks), or vehicle (four weeks). Functional assessments were repeated during the final two weeks, alongside assessment of flicker-evoked retinal vasodilation. After bulk RNA sequencing of retinal tissue, differential gene expression analysis alongside weighted gene co-expression network analysis were performed to determine disease- and treatment-sensitive changes in retinal gene co-expression that correlated with functional protection. RESULTS: After L-DOPA treatment in diabetic mice, ERG oscillatory potential timing and OMR performance were protected for at least two weeks past treatment end. Flicker-induced venule vasodilation also maintained post-treatment improvement, with protective trends in arteriole vasodilation. Differentially expressed genes were comparable between diabetic mice experiencing L-DOPA washout versus continued L-DOPA treatment. Gene co-expression network analysis identified distinct modules across L-DOPA-treated diabetic mice associated with synaptic function and cytoskeletal organization that correlated with functional protection. CONCLUSIONS: These findings demonstrate that L-DOPA restores retinal neurovascular function with post-treatment effects in early DR and links this protection to transcriptional programs supporting synapse activity and structural integrity.
引用
- Chlan E, Li C, Bales KL, et al. L-DOPA Promotes Post-Treatment Neurovascular and Synaptic Homeostasis in Early Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2026. PMID: 42474422. doi:10.1167/iovs.67.8.42
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。